|
|
Prepublished online as a Blood First Edition Paper on June 21, 2002; DOI 10.1182/blood-2002-03-0770.
Previous Article | Table of Contents | Next Article 
Blood, 15 October 2002, Vol. 100, No. 8, pp. 2832-2838
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
The von Willebrand factor-reducing activity of thrombospondin-1
is located in the calcium-binding/C-terminal sequence and requires a
free thiol at position 974
John E. Pimanda,
Douglas S. Annis,
Mark Raftery,
Deane F. Mosher,
Colin N. Chesterman, and
Philip J. Hogg
From the Centre for Thrombosis and Vascular Research
and Cytokine Research Unit, School of Medical Sciences, University of
New South Wales and Department of Haematology, Prince of Wales
Hospital, Sydney, Australia; and Section of Hematology, Department of
Medicine, University of Wisconsin, Madison.
Plasma von Willebrand factor (VWF) is a multimeric protein that
mediates adhesion of platelets to sites of vascular injury; however,
only the very large VWF multimers are effective in promoting platelet
adhesion in flowing blood. The multimeric size of VWF can be controlled
by the glycoprotein, thrombospondin-1 (TSP-1), which facilitates
reduction of the disulfide bonds that hold VWF multimers together. The
TSP family of extracellular glycoproteins consists of 5 members in
vertebrates, TSP-1 through TSP-4 and TSP-5/COMP. TSP-1 and TSP-2 are
structurally similar trimeric proteins composed of disulfide-linked
150-kDa monomers. Recombinant pieces of TSP-1 and TSP-2 incorporating
combinations of domains that span the entire subunit were produced in
insect cells and examined for VWF reductase activity. VWF reductase
activity was present in the Ca++-binding repeats and
C-terminal sequence of TSP-1, but not of TSP-2. Alkylation of Cys974 in
the C-terminal TSP-1 construct, which is a serine in TSP-2, ablated VWF
reductase activity. These results imply that the reductase function of
TSP-1 centers around Cys974 in the C-terminal sequence.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Ahamed, H. H. Versteeg, M. Kerver, V. M. Chen, B. M. Mueller, P. J. Hogg, and W. Ruf
Disulfide isomerization switches tissue factor from coagulation to cell signaling
PNAS,
September 19, 2006;
103(38):
13932 - 13937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Zwicker, F. Peyvandi, R. Palla, R. Lombardi, M. T. Canciani, A. Cairo, D. Ardissino, L. Bernardinelli, K. A. Bauer, J. Lawler, et al.
The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size
Blood,
August 15, 2006;
108(4):
1280 - 1283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Glerup, H. B. Boldt, M. T. Overgaard, L. Sottrup-Jensen, L. C. Giudice, and C. Oxvig
Proteinase Inhibition by Proform of Eosinophil Major Basic Protein (pro-MBP) Is a Multistep Process of Intra- and Intermolecular Disulfide Rearrangements
J. Biol. Chem.,
March 18, 2005;
280(11):
9823 - 9832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-l. A. Hannah, T. M. Misenheimer, M. M. Pranghofer, and D. F. Mosher
A Polymorphism in Thrombospondin-1 Associated with Familial Premature Coronary Artery Disease Alters Ca2+ Binding
J. Biol. Chem.,
December 10, 2004;
279(50):
51915 - 51922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Pimanda, T. Ganderton, A. Maekawa, C. L. Yap, J. Lawler, G. Kershaw, C. N. Chesterman, and P. J. Hogg
Role of Thrombospondin-1 in Control of von Willebrand Factor Multimer Size in Mice
J. Biol. Chem.,
May 14, 2004;
279(20):
21439 - 21448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Pimanda, A. Maekawa, T. Wind, J. Paxton, C. N. Chesterman, and P. J. Hogg
Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13
Blood,
January 15, 2004;
103(2):
627 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-l. A. Hannah, T. M. Misenheimer, D. S. Annis, and D. F. Mosher
A Polymorphism in Thrombospondin-1 Associated with Familial Premature Coronary Heart Disease Causes a Local Change in Conformation of the Ca2+-binding Repeats
J. Biol. Chem.,
March 7, 2003;
278(11):
8929 - 8934.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|